image
SCHWEIZ SPITAL CHUV DOWN-SYNDROM
EMBARGO UNTIL 1. SEPTEMBER 2022 AT 20 PM CET - Switzerland's professor Nelly Pitteloud, Head of the Department of Endocrinology, Diabetology and Metabolism poses for the photographer during a study of GnRH replacement rescues cognition in Down Syndrome at the University Hospital (CHUV), in Lausanne, Switzerland, Monday, August 22, 2022. The Institut at national de la sante et de la recherche medicale (Inserm, Lille), and the Centre hospitalier universitaire vaudois (CHUV, Lausanne) have collaborated to test the efficacy of a therapy based on the injection of the hormone GnRH to improve the cognitive functions of a small group of patients with Down syndrome. (KEYSTONE/Laurent Gillieron)
Instructions
EMBARGO UNTIL 1. SEPTEMBER 2022 AT 20 PM CET
Licence
Rights Managed
Date de création
20220901
Lieu
LAUSANNE SCHWEIZ
Credit
KEYSTONE
Source
KEYSTONE
Byline
LAURENT GILLIERON
Taille
7738 x 5159 px
Type de fichier
JPEG